There was a significant increase in co-localisation values for TRPM3 with PIP2 in PregS (30 μM) + ononetin (3 μM) treated NK cells in ME/CFS patients compared with HC (PCC, p = 0.0408) (Fig. 6). The gene discussed is TRPM3; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.